Bio - John E. Reardon, Ph.D.

	John E. Reardon, Ph.D.
John E. Reardon, Ph.D., is the Executive Vice President and Chief Scientific Officer at Integrated Oncology Solutions, Inc., a biopharmaceutical company headquartered in Research Triangle Park, NC. Prior to joining IOS Dr. Reardon was the Senior Vice President of Discovery Research Biology at GlaxoSmithKline with responsibility for the majority of biological science supporting gene-to-function-to-target-to-lead activities in the international GSK R&D organization. Dr. Reardon received his Ph.D. degree in Chemistry from The Ohio State University and did post-doctoral research with Dr. Robert Abeles at Brandeis University before beginning a career in the pharmaceutical industry. He joined Burroughs Wellcome Co. in 1987 as a Research Scientist where he contributed to the discovery and development of several anti-viral compounds.

John E. Reardon, Ph.D.

John E. Reardon, Ph.D., is the Executive Vice President and Chief Scientific Officer at Integrated Oncology Solutions, Inc., a biopharmaceutical company headquartered in Research Triangle Park, NC. Prior to joining IOS Dr. Reardon was the Senior Vice President of Discovery Research Biology at GlaxoSmithKline with responsibility for the majority of biological science supporting gene-to-function-to-target-to-lead activities in the international GSK R&D organization. Dr. Reardon received his Ph.D. degree in Chemistry from The Ohio State University and did post-doctoral research with Dr. Robert Abeles at Brandeis University before beginning a career in the pharmaceutical industry. He joined Burroughs Wellcome Co. in 1987 as a Research Scientist where he contributed to the discovery and development of several anti-viral compounds.